
Please try another search
Mitsubishi Tanabe Pharma Corporation engages in the manufacture and sale of pharmaceuticals and OTC products in Japan, Europe, North America, other Asian countries, and internationally. The company primarily offers drugs for the central nervous system, immuno-inflammation, diabetes and kidney disorders, and vaccines for influenza, measles and rubella, encephalitis, diphtheria, pertussis, tetanus, and poliomyelitis. It also provides OTC products, including skin-treating agents, digestive drinks and medicines, and nutrient foods. The company was founded in 2007 and is headquartered in Osaka, Japan with sales offices in Hokkaido, Tohoku, Kitakantokoshinetsu, Tokyo, Chiba, Saitama, Tokai, Yokohama, Kyoto, Osaka, Kobe, Chushikoku, and Kyushu, Japan; and research centers in Yokohama, Onada, and Shonan, Japan.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review